Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01791543 · ClinicalTrials.gov registry record · NA
Intramural Needle Ablation for Ablation of Recurrent Ventricular Tachycardia
A NA study of Ventricular Tachycardia, sponsored by William Stevenson.
- Completed
- Registry status
- NA
- Development phase
- 115
- Enrollment target
- 2
- Study locations
NCT01791543: Completed NA study of Ventricular Tachycardia, sponsored by William Stevenson.
NCT01791543 is a NA study of Ventricular Tachycardia that has completed, run by William Stevenson. The registered enrollment target is 115 participants, below the 285-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (60% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01791543, a NA study of Ventricular Tachycardia, has completed, sponsored by William Stevenson.
- COMPLETED
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the study is to assess the effectiveness and safety of a new device called an Intramural Needle Ablation Catheter (INA catheter). The INA catheter is used for locating and ablating ventricular arrhythmias that have failed standard radiofrequency ablation. This approach is desirable because some people have ventricular arrhythmias that originate deep within the heart muscle where it is not abolished by ablation with standard catheters. The investigators seek to determine whether the INA catheter can potentially help people who have ventricular arrhythmias that have failed standard radiofrequency ablation. The investigators also want to determine if it is likely to be safe, without excessive side effects.
Primary Outcome
Freedom from hospitalization for recurrent Ventricular Tachycardia during the 6 months following ablation for VT.
Conditions Studied
Interventions
- DEVICE Intramural Needle Ablation Catheter
Study Locations (2)
Massachusetts
- Brigham and Women's Hospital - Boston
Tennessee
- Vanderbilt Heart and Vascular Institute - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2016-09 |
| Est. Completion | 2022-05-27 |
| Phase | NA |
What the finished NCT01791543 record still lists
NCT01791543 is an interventional study that assigns participants to a tested intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap, below the 285-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (60% lower).
The record links to 1 condition, with Ventricular Tachycardia appearing as the primary indexed condition, and to 1 intervention - of which Intramural Needle Ablation Catheter is the first listed.
NCT01791543 reports a single indexed study location in Massachusetts, Tennessee.
Frequently Asked Questions
What is clinical trial NCT01791543 about?
NCT01791543 is a clinical study titled "Intramural Needle Ablation for Ablation of Recurrent Ventricular Tachycardia". The purpose of the study is to assess the effectiveness and safety of a new device called an Intramural Needle Ablation Catheter (INA catheter). The INA catheter is used for locating and ablating ventricular arrhythmias that have failed standard radiofrequency ablation. This approach is desirable be...
What is the current status of trial NCT01791543?
This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2016-09. Estimated completion is 2022-05-27.
What conditions does trial NCT01791543 study?
This clinical trial studies the following conditions: Ventricular Tachycardia.
What interventions are being tested in trial NCT01791543?
The interventions under investigation include: Intramural Needle Ablation Catheter (DEVICE).
Who is sponsoring clinical trial NCT01791543?
This trial is sponsored by William Stevenson, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01791543 being conducted?
This trial has 2 study locations across Massachusetts, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventricular Tachycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01791543's enrollment target sits among peer trials
115 15th of 28 higher than 14 of 28 other Ventricular Tachycardia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ventricular Tachycardia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ventricular Tachycardia Mechanisms
RECRUITING · NA
-
Randomized Assessment of TcMS for VT Storm
RECRUITING · NA
-
Cardiac Radioablation for VT
RECRUITING · NA
-
Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic Cardiomyopathy
RECRUITING · NA
-
Pulsed Field Ablation for Post-Infarction Ventricular Tachycardia
RECRUITING · NA
-
The Z Stitch Early Bed Rest Assessment Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02346929 · 115 participants · NA
Hematoma Block for Distal Radius Fracture
- NCT03394365 · 115 participants · Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- NCT03907475 · 115 participants · Phase 2
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
- NCT05086692 · 115 participants · Phase 1
A Beta-only IL-2 ImmunoTherapY Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia